Cannabis Law Report

NOVEMBER 22, 2019

MMJ International Holdings, the premier medical cannabis research company, announced that it has received DEA approval to ship THC and CBD from Canada. “Patients will benefit from cGMP-quality therapies in an accessible and efficient format.”. . Most recently the FDA awarded MMJ International Holdings ?

DEA 66

DEA Clinical Trials THC Research and Development 66

Veriheal

NOVEMBER 6, 2023

states and the District of Columbia currently have legal cannabis, medical or recreational. Despite this massive shift in cannabis policy, however, a few states are still dragging their feet on cannabis legalization. Idaho Idaho is one of the staunchest anti-cannabis states. Like Idaho, CBD with less than.3%

Legalization 117

Legalization Recreational THC CBD 117

FloridaMarijuana.net

JULY 8, 2018

5 cannabis strains to treat PTSD? The National Academies of Sciences reports that PTSD is a stressor-related disorder which develops as a result of a patient’s exposure to a traumatic event. When the body is defensive against trauma or illness, this system begins to fail, resulting in physical, mental and/or neurological conditions.

Strains 190

Strains Indica Hybrid Research and Development 190

MedicalJane

JUNE 29, 2018

At the time of this article’s publishing, thirty states and the District of Columbia have enacted legislation permitting use of medical cannabis. Do you qualify for medical cannabis? There is no universal handbook for a medical cannabis program. Can your current doctor “prescribe” cannabis?

Patients 83

Patients Legalization Conditions Treatment 83

The Blunt Truth

DECEMBER 15, 2023

The Department of Health and Human Services released documents related to rescheduling cannabis. The DEA sends a letter to Georgia pharmacies. And finally, if you’re planning a wedding, you have a cannabis option. Well, apparently the Drug Enforcement Administration (DEA) noted that as well, and they didn’t take kindly to it.

DEA 59

DEA Legislation Legalization Consumption 59

Veriheal

APRIL 11, 2022

Cannabis, despite being widely available for medical and recreational consumers across the United States, remains one of the most understudied plants. federal government is granting a handful of American companies the option to cultivate and study cannabis for medical research purposes. Drug Enforcement Agency (DEA).

Pharmaceutical 104

Pharmaceutical Research and Development DEA Clinical Trials 104

Freedom Leaf

OCTOBER 15, 2018

On September 28, the DEA designated Epidiolex —a plant-based CBD pharmaceutical manufactured by the UK-based GW Pharmaceuticals—a Schedule V drug in the government’s list of controlled substances. schedules were created by the Controlled Substances Act (CSA) in 1970 and are interpreted and enforced by the DEA.

DEA 51

DEA CBD Pharmaceutical Epilepsy 51

Veriheal

NOVEMBER 11, 2023

Many states in the US have legalized cannabis, thirty-eight states to be exact. Despite the widespread adoption, the Food and Drug Administration still classifies cannabis as a Schedule One drug. Simply put, in the eyes of federal law, cannabis is illegal. Is Medical Cannabis Legal? allow the use of medical cannabis.

Law 62

Law Chronic Pain Conditions Legislation 62

Veriheal

SEPTEMBER 13, 2022

The legal cannabis industry in the United States has slowly expanded over the last decade. Despite the federal illegality of cannabis, lawmakers and state representatives have implemented successful medical and recreational cannabis programs across the nation. Homegrown Cannabis Statistics: Supplies, Growers and Products .

Cultivation 109

Cultivation Data DEA Dispensary 109

United Patients Group

FEBRUARY 21, 2023

Understanding the 4 Major Differences Between CBD and THC CBD and THC are both compounds that can be found in the Cannabis plant. THC CBD is derived from the Cannabis sativa plant, with hemp and cannabis being the primary sources. They can both help to reduce symptoms associated with a variety of conditions.

THC 52

THC CBD Patients DEA 52

Veriheal

DECEMBER 28, 2021

Over the last few decades, the cannabis plant and its many components have been the focal point of research and stiff debate. D espite the Drug Enforcement Agency’s (DEA) announcement in May that it would soon start reviewing grower applications for research purposes, cannabis research continues to be tightly restricted.

Research and Development 98

Research and Development Chronic Pain Treatment Medicine 98

Cannabis Law Report

JULY 7, 2019

RE-PUBLISHED BY : CANNABIS LAW REPORT. Notwithstanding, this re-branding and imaging of cannabis, the basis for much of this confusion is the Controlled Substances Act. As a refresher, cannabis is classified as a “Schedule I” substance, which, defines it as a substance with no currently accepted medical use. De Ingeniis.

DEA 40

DEA Pharmaceutical Conditions Patients 40

Veriheal

DECEMBER 1, 2020

Cannabis was labeled with a stigma and stereotype that is very difficult to break. Years of negative propaganda at the hands of the US federal government has painted a picture of cannabis consumers being lazy, unmotivated individuals having no motivation, drive, or desire to be good contributing members of society.

THC 52

THC DEA Research and Development Cannabinoids 52

Veriheal

AUGUST 31, 2020

Add onto that the difficulty of these unprecedented times, as a minority-owned business, we’re making it our priority to pay it forward and invest in the future leaders of cannabis who will break barriers and pave the way for innovation in this burgeoning industry. . Veriheal’s Innovation in Cannabis Scholarship 2020 Winners .

Research and Development 117

Research and Development Education Agriculture Patients 117

CannaMD

SEPTEMBER 15, 2020

Current Florida medical marijuana patient? MORE DETAILS: On June 16, 2014, Florida became the 22nd state to legalize (at least partial) access to medical marijuana when Governor Rick Scott signed the Compassionate Medical Cannabis Act of 2014. Qualified patient. Thinking about getting your card? What about travel?

Law 126

Law Marijuana Patients Treatment 126

CannaMD

AUGUST 8, 2020

– because today’s post is a deep dive into everything you need to know about the most popular cannabis compound around. Let’s clear up one of the biggest sources of confusion right off the bat: CBD is a cannabis compound called cannabidiol. Researchers believe cannabis contains over 100 unique chemical compounds!

CBD 100

CBD DEA Research and Development Hemp 100

PrestoDoctor

FEBRUARY 6, 2023

Are you interested in using medical marijuana or medical cannabis? The physician will conduct an evaluation to determine if your medical condition can improve with marijuana use. Oklahoma does not have a specific list of conditions to get a MMJ recommendation. Qualifying conditions vary from state to state.

Marijuana 52

Marijuana Patients Conditions Access 52

Canna Care Docs

SEPTEMBER 26, 2019

Canna Care Docs is the center of excellence for cannabis medicine. Powered by Sail, we are on a mission to solve the issue of cannabis access for patients. We’re passionate about improving our patient’s quality of life and bringing cannabis into mainstream healthcare. About Canna Care Docs….

DEA 40

DEA History Therapy Patients 40

Cannabis Law Report

MAY 29, 2022

8] Spravato is derived from ketamine and categorized by DEA as a Schedule III controlled substance. To mitigate safety risks, FDA implemented a Risk Evaluation and Mitigation Strategy (REMS) with elements to assure safe use (ETASU) whereby patients self-administer the spray in their healthcare provider’s office under medical supervision.

Research and Development 52

Research and Development DEA Clinical Trials Therapy 52

SpeedWeed

AUGUST 11, 2021

MAPS, The Multidisciplinary Association for Psychedelic Substances, was awarded a $12,979,050 million grant from the state of Michigan to fund a study on PTSD and cannabis on August 10. This grant enables more rigorous study, overseen by the FDA, which may lead to cannabis flower becoming prescribable medicine someday.

Clinical Trials 52

Clinical Trials Research and Development Pharmaceutical DEA 52

Cannabis Law Report

AUGUST 18, 2022

“We are at the beginning of a revolution in how mental health conditions are medically treated. Psychedelics present a new potential path to relief for patients who continue to struggle with mental health conditions despite conventional therapies,” he added. Tweet this. However, change appears imminent.

Therapy 52

Therapy Research and Development Pharmaceutical Treatment 52

Veriheal

OCTOBER 17, 2021

In 1970 cannabis was federally placed as a Schedule I drug in the US, a category that is tightly restricted and reserved for drugs not medically accepted. According to the US schedule 1 of controlled substances , cannabis is actually in a class of its own called Tetrahydrocannabinols. Responses to Cannabis Vary Significantly.

Terpenes 103

Terpenes Strains THC Cannabis 103

The Joint Blog

JULY 12, 2019

As noted by the AP, the government is the only source of cannabis for nearly all research in the U.S., The crop will be divided between high THC and high CBD varieties with “recent interest (in CBD) as a potential medicine for a number of medical conditions,” NIDA said. while it still considers it illegal and dangerous.

DEA 44

DEA Marijuana THC CBD 44

Cannabis Law Report

OCTOBER 31, 2019

The Oregon State Police (OSP) Northwest Region Marijuana Team executed a search warrant at a property near Dexter, which resulted in the confiscation of approximately 216 pounds (100,000mL) of cannabis extracts, two butane hash oil extraction machines valued at $120,000, as well as ten firearms.

Oil 45

Oil Extraction Hash Marijuana 45

Cannabis Law Report

JULY 9, 2021

Patients would participate in therapy sessions to prepare for the use of psychedelics, after which the substances would be administered under the guidance and supervision of trained medical professionals. Right to Try laws permit patients with serious or life-threatening diseases to access drugs that do not yet have government approval.

Law 105

Law Therapy Clinical Trials Research and Development 105

SpeedWeed

MARCH 5, 2021

Having spent more than 25 years studying cannabis policy and scheduling, I take issue with this interpretation. Bilmoria opine: “[R]emoving cannabis from Schedule I of the CSA would mean that it could be treated as any other physician-prescribed drug. Authors Tracy Gallegos and Neville M.

Business 52

Business Policy Clinical Trials Research and Development 52

The Blunt Truth

OCTOBER 3, 2019

Plus, a new bill would legalize cannabis with state-run stores. In Minnesota , lawmakers are conducting “Be Heard on Cannabis” discussions, so that citizens can share their views on legal marijuana. Also in New Mexico , growers of medical cannabis are suing the state over limits on plant-count.

Chronic Pain 77

Chronic Pain Hemp DEA Programs 77

CannaMD

MAY 6, 2020

However, given rapidly evolving – and often complicated – laws surrounding medical marijuana, many patients feel overwhelmed. Just like using medical marijuana in residential apartments , traveling with cannabis comes down to federal versus state law. For more information, see: The California Cannabis Portal. CALIFORNIA.

Hash 103

Hash Legalization Marijuana Concentrates 103

Cannabis Law Report

APRIL 21, 2022

Publication of this process establishes “prior art,” contributing to MAPS’ patient access strategy by making intellectual property public . 30,000 patient doses) of MDMA in a four-step process beginning with a non-controlled starting material. The chemical purity of the final product exceeded 99.9%

Clinical Trials 52

Clinical Trials Research and Development Therapy Media 52

The Cannigma

MAY 1, 2023

2 3 As clinical trials around the world proceeded in the late 1960s and 1970s, patients began reporting difficulty tolerating ketamine’s unpleasant hallucinogenic and dissociative properties. It was also after the Vietnam War that widespread ketamine abuse would begin to show up as a party drug. 9 How is ketamine commonly used?

Blood Pressure 80

Blood Pressure Chronic Pain Research and Development Clinical Trials 80

Cannabis Law Report

JANUARY 13, 2022

In The Weeds welcomes the new year, as well as a number of new cannabis laws and policies taking effect around the country in 2022. 1, Louisiana’s medical cannabis program allows patients to access smokable whole-plant flower marijuana. McGuireWoods LLP. Newsworthy Highlights. Happy 2022! Montana: As of Jan. 14, 2021, alert ).

Dispensary 52

Dispensary Law Concentrates DEA 52

The Joint Blog

AUGUST 5, 2019

The crop will be divided between high THC and high CBD varieties with “recent interest (in CBD) as a potential medicine for a number of medical conditions,” NIDA said. Last year, a CBD-based drug was approved by federal regulators for two rare seizure disorders and researchers are pursuing research on it for other conditions.

DEA 38

DEA Marijuana THC CBD 38

CannaMD

NOVEMBER 20, 2020

a wealth of new research legitimizing marijuana’s role in patient care – here we are. Making matters worse, there’s only one farm in the entire country with DEA approval to cultivate marijuana for research purposes. Cannabis vs. Opioids. For more details, see: Best Cannabis Disorder Treatment? More Cannabis.

Therapy 80

Therapy Treatment DEA CBD 80

PrestoDoctor

JANUARY 14, 2020

For individuals who need marijuana or cannabis for medical reasons, they must get an MMJ. The physician will conduct an evaluation to determine if your medical condition can improve with marijuana use. The physician may review a list of qualifying conditions. Oklahoma does not have a specific list of conditions to get an MMJ.

Marijuana 52

Marijuana Patients Conditions Programs 52

PrestoDoctor

JANUARY 14, 2020

For individuals who need marijuana or cannabis for medical reasons, they must get an MMJ. The physician will conduct an evaluation to determine if your medical condition can improve with marijuana use. The physician may review a list of qualifying conditions. Oklahoma does not have a specific list of conditions to get an MMJ.

Marijuana 52

Marijuana Patients Conditions Programs 52

Cannabis Law Report

SEPTEMBER 20, 2019

They write… In this week’s edition: Plans to vote on cannabis banking legislation announced in both chambers of Congress, with predictions that House will pass the SAFE Act by the end of October. DEA increases the cannabis research quota. Battle heating up over Florida ballot initiative to legalize cannabis for adult use.

Vaping 40

Vaping Banking Research and Development DEA 40

Veriheal

JUNE 29, 2021

In order to legally access other therapies including nature-based options such as psilocybin , you must gain access under a Right to Try law which requires you to have a terminal condition. A Push by Patients. Along with patients, a Seattle-based palliative care physician by the name of Dr. Sunil Aggarwal was also named in the lawsuit.

Therapy 64

Therapy DEA Patients Clinical Trials 64